Rhythm Pharmaceuticals

AstraZeneca made $10B bid for Rhythm, WSJ reports

AstraZeneca made an offer of about $10 billion for Rhythm Pharmaceuticals, a company that treats rare genetic forms of obesity, as reported by The Wall Street Journal News Corp on Wednesday, November 4. The paper's sources said the British drugmaker…

You're all caught up

You've seen all the main stories from the past 2 days.